Workflow
SELLAS Life Sciences Group, Inc. (SLS) Discusses Innovation in AML Treatments With Focus on GPS and SLS009 Programs Transcript

PresentationGood morning, and welcome to the SELLAS Life Sciences R&D Day. As a reminder, this call is being recorded, and a replay will be made available on the SELLAS website following the conclusion of the event. I'd now like to turn the call over to your host, Dr. Angelos Stergiou, President and Chief Executive Officer at SELLAS Life Sciences. Please go ahead, Angelos.Angelos StergiouFounder, President, CEO & Director Good morning, and welcome to SELLAS' R&D Day. Thank you all for joining us today. I wo ...